Cadila Healthcare has slipped almost 7% to Rs 888 after reporting 200 basis points drop in operating profit margins (OPM) to 26% for the first quarter ended June 30.
Meanwhile, the company has posted 15% year-on-year rise in its consolidated net profit at Rs 230 crore for Q1FY12. The company had recorded a net profit of Rs 199 crore in a year ago period. Without considering the dossier income, the growth in net profit was 19%, the pharmaceutical firm said in a filing to the stock exchanges.
Net sales grew 11% to Rs 1,174 crore from Rs 1,055 crore during the recently concluded quarter.
The stock opened at Rs 866, have seen a combined around 109,182 shares changing hands on the counter till 0949 hours.
